STRESS BIOMARKER
    15.
    发明申请
    STRESS BIOMARKER 审中-公开

    公开(公告)号:US20190119747A1

    公开(公告)日:2019-04-25

    申请号:US16089317

    申请日:2017-03-28

    Abstract: The principal purpose of the present invention is to provide a novel stress biomarker that makes it possible to conveniently and accurately assess a state of stress. In addition, the present invention provides a diagnosis kit containing a reagent capable of detecting said biomarker, and a diagnosis method that uses said biomarker. It is possible to use mitochondrial DNA included in a biological fluid as the stress biomarker.

    METHOD FOR PRODUCING A CORNEAL EPITHELIAL CELL POPULATION

    公开(公告)号:US20210332324A1

    公开(公告)日:2021-10-28

    申请号:US16476521

    申请日:2017-12-27

    Abstract: The present invention provides a method for producing a corneal epithelial cell population for the fabrication of corneal epithelial cell sheets for transplantation, the method comprising the steps of: (1) preparing a cell population containing corneal epithelial cells; (2) subjecting the cell population prepared in step (1) to magnetic-activated cell sorting and collecting CD200-negative/SSEA-4-positive cells; and (3) bringing the cells collected in step (2) into contact with a laminin selected from the group consisting of a laminin having an α3 chain, a laminin having an α4 chain and a laminin having an α5 chain, or an E8 fragment thereof, and collecting cells adherent thereto.

    METHOD FOR INDUCING DIFFERENTIATION INTO PLURIPOTENT STEM CELL-DERIVED CONJUNCTIVAL CELLS

    公开(公告)号:US20210207087A1

    公开(公告)日:2021-07-08

    申请号:US17057021

    申请日:2019-05-22

    Abstract: Provided is a method for inducing differentiation into conjunctival epithelial cells, conjunctival goblet cells, and conjunctival epithelial stem and progenitor cells, the method comprising culturing colonies of pluripotent stem cells in a medium containing an epidermal growth factor (EGF) signaling activator to induce differentiation of the pluripotent stem cells. The present invention enables differentiation of pluripotent stem cells including iPS cells into conjunctival epithelial cells, conjunctival goblet cells, and conjunctival epithelial stem and progenitor cells and therefore is very useful for, for example, basic research on conjunctival epithelial cells and conjunctival goblet cells, regenerative therapy for intractable ocular surface diseases, and research related to the diseases.

Patent Agency Ranking